Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Call for greater access to animal medicine
drugs
"One of the major reasons attributable for the lack of availability and accessibility of quality veterinary medicines and vaccines is the lack of an appropriate, robust and functioning regulatory system."

Conference highlights the need for government collaboration 

The global animal medicines association, HealthforAnimals, has appealed for greater worldwide access to veterinary medicines. The organisation, speaking at the fifth Global Animal Health Conference in Delhi, urged representatives from 24 countries to improve regional cooperation in order to improve the availability of animal medicines.
 
The conference, supported by the Bill and Melinda Gates Foundation, emphasised the socio-economic benefits of providing farmers with access to quality animal health products. Through enabling access, livestock can be immunised and treated for disease, ensuring the livelihood of communities and protecting against transferable diseases.
 
Opening the conference, Dr. Samuel Thevasagayam, Deputy Director of Agricultural Development at the Bill and Melinda Gates Foundation said:
“Approximately 60 per cent of smallholder farmers depend on livestock for their wellbeing in Africa and South Asia. It is estimated that 25 per cent of livestock production is lost due to preventable or treatable diseases. One of the major reasons attributable for the lack of availability and accessibility of quality veterinary medicines and vaccines is the lack of an appropriate, robust and functioning regulatory system.

“We are working, with our partners in the animal health industry and regulatory agencies, to establish a robust regulatory framework that is effective, transparent and predictable to address this massive need to eliminate the leakage of value from livestock production and help small holder farmers realise the value of livestock by further investing in feed, livestock genetics and improved husbandry.”

Closing the conference, HealthforAnimals’ executive director, Carel du Marchie Sarvaas said: “The purpose of the conference was to bring together people from a range of sectors to help build a greater bond, and in turn, better animal health. A key theme of the day has been harmonisation. Chiefly the need for regulators and governments to collaborate together with other stakeholders.

“Access to quality veterinary medicines not only protect animals but humans, their livelihoods and wellbeing. We hope all those at the conference apply and share today’s learnings to help us all make animals healthier.”
 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.